Advanced Stage NSCLC
This frontal view x-ray of the chest shows advanced stage non-small cell lung cancer (NSCLC) of a 50-year-old woman with a long history of smoking and emphysema. The orange area depicts collapsed lung tissue at the base of the right lung, and the yellow area highlights a pleura-based density along the right hemithorax.
Fluorodeoxyglucose FDG-PET Scan
Fluorodeoxyglucose positron emission tomography (FDG-PET) scan of the chest (axial section) shows cancer in the right lung. The rapidly growing, highly metabolic cancer cells of the tumor take up the FDG, causing a distinguished appearance from the other lung tissue cells/benign tumors. FDG is useful in diagnosing, staging, and following tumors.
CT scan of the axial section of the thorax highlighting bronchopulmonary small cell lung cancer (SCLC) with a large middle mediastinum mass.
PET/CT Fusion Imaging
The PET/CT fusion image shows non-small cell lung cancer (NSCLC) of the right lung, with an early stage of another type of cancer showing up in the yellow/pink highlighted area. PET/CT fusion imaging is a multimodality technology that allows the correlation of findings from two concurrent imaging modalities.
3D CT Scan Model
Posterior view of a 3D CT scan model showing advanced non-small cell lung cancer (NSCLC) in a patient who had a long history of smoking and emphysema. The large pleura-based mass (green) has eroded through the ribs and thoracic vertebrae.
MRI Scan Showing SCLC
MRI scan of the abdomen highlighting small cell lung cancer (SCLC).
Lung Tumor Invading an Alveolus
Electron microscope using a colored scan to highlight a lung tumor (red) invading an alveolus. The cancer cells are covered with microvilli.
Masses in Both Lungs
Color coded chest x-ray showing masses (orange silhouettes) in both lungs.
Small Cell Lung Cancer
Colored coded chest x-ray highlighting small cell lung cancer (SCLC) represented in orange.
More people in the United States die from lung cancer than any other type of cancer. This is true for both men and women. According to the most currently available epidemiologic data from the US Centers for Disease Control and Prevention, 208,493 people were diagnosed with lung cancer in 2008, including 111,886 men and 96,607 women; among those, there were a total of 158,592 deaths from lung cancer. A recent report from the American Cancer Society estimates that there will be a total of 226,160 newly diagnosed cases of lung cancer in the US in 2012; of these, 160,340 will die of the disease.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|